The most common BRAF mutation is the BRAF V600E missense mutation6, which is present in 60% to 70% of patients with papillary thyroid cancer (PTC), 60% of those with melanoma, and 18% of those with CRC7. Here, BRAF is linked to thyroid gland papillary carcinoma.